{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:47:29Z","timestamp":1789026449943,"version":"build-2803163510"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010699","name":"Monash University Malaysia","doi-asserted-by":"publisher","award":["#SED000125"],"award-info":[{"award-number":["#SED000125"]}],"id":[{"id":"10.13039\/501100010699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001675","name":"International Brain Research Organization","doi-asserted-by":"publisher","award":["#PM010CNI000148"],"award-info":[{"award-number":["#PM010CNI000148"]}],"id":[{"id":"10.13039\/501100001675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-07790-w","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T14:06:01Z","timestamp":1740924361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Integrated transcriptomic profiling reveals a STING-mediated Type II Interferon signature in SOD1-mutant amyotrophic lateral sclerosis models"],"prefix":"10.1038","volume":"8","author":[{"given":"Jen Young","family":"Hiew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Shan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huitao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3169-5795","authenticated-orcid":false,"given":"Chen Seng","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,2]]},"reference":[{"key":"7790_CR1","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"M. A van Es","year":"2017","unstructured":"van Es, M. A. et al. Amyotrophic lateral sclerosis. Lancet 390, 2084\u20132098 (2017).","journal-title":"Lancet"},{"key":"7790_CR2","doi-asserted-by":"publisher","first-page":"e200109","DOI":"10.1212\/NXG.0000000000200109","volume":"9","author":"J Barberio","year":"2023","unstructured":"Barberio, J., Lally, C., Kupelian, V., Hardiman, O. & Flanders, W. D. Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis. Neurol. Genet. 9, e200109 (2023).","journal-title":"Neurol. Genet."},{"key":"7790_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"A. E Renton","year":"2011","unstructured":"Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257\u2013268 (2011).","journal-title":"Neuron"},{"key":"7790_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"D. R Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362 (1993).","journal-title":"Nature"},{"key":"7790_CR5","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"T. J Kwiatkowski","year":"2009","unstructured":"Kwiatkowski, T. J. et al. Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205\u20131208 (2009).","journal-title":"Science"},{"key":"7790_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ng.132","volume":"40","author":"E Kabashi","year":"2008","unstructured":"Kabashi, E. et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572\u2013574 (2008).","journal-title":"Nat. Genet."},{"key":"7790_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2012.10.008","volume":"53","author":"M. C Evans","year":"2013","unstructured":"Evans, M. C., Couch, Y., Sibson, N. & Turner, M. R. Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 53, 34\u201341 (2013).","journal-title":"Mol. Cell. Neurosci."},{"key":"7790_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu, J. & Wang, F. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front. Immunol. 8, 1005 (2017).","journal-title":"Front. Immunol."},{"key":"7790_CR9","doi-asserted-by":"publisher","first-page":"a018812","DOI":"10.1101\/cshperspect.a020628","volume":"7","author":"H Phatnani","year":"2015","unstructured":"Phatnani, H. & Maniatis, T. Astrocytes in neurodegenerative disease. Cold Spring Harb. Perspect. Biol. 7, a018812 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"7790_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1073\/pnas.1314085111","volume":"111","author":"K Meyer","year":"2014","unstructured":"Meyer, K. et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl. Acad. Sci. USA 111, 829\u2013832 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7790_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","volume":"8","author":"A Verkhratsky","year":"2023","unstructured":"Verkhratsky, A. et al. Astrocytes in human central nervous system diseases: a frontier for new therapies. Signal Transduct. Target. Ther. 8, 396 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"7790_CR12","doi-asserted-by":"publisher","first-page":"17803","DOI":"10.1073\/pnas.1103141108","volume":"108","author":"S. T Papadeas","year":"2011","unstructured":"Papadeas, S. T., Kraig, S. E., O\u2019Banion, C., Lepore, A. C. & Maragakis, N. J. Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc. Natl. Acad. Sci. USA 108, 17803\u201317808 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7790_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2015.02.017","volume":"77","author":"B. J Murdock","year":"2015","unstructured":"Murdock, B. J., Bender, D. E., Segal, B. M. & Feldman, E. L. The dual roles of immunity in ALS: injury overrides protection. Neurobiol. Dis. 77, 1\u201312 (2015).","journal-title":"Neurobiol. Dis."},{"key":"7790_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104404","volume":"25","author":"H. Y Tan","year":"2022","unstructured":"Tan, H. Y. et al. cGAS and DDX41-STING mediated intrinsic immunity spreads intercellularly to promote neuroinflammation in SOD1 ALS model. iScience 25, 104404 (2022).","journal-title":"iScience"},{"key":"7790_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","volume":"183","author":"C.-H Yu","year":"2020","unstructured":"Yu, C.-H. et al. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS\/STING in ALS. Cell 183, 636\u2013649.e18 (2020).","journal-title":"Cell"},{"key":"7790_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2625-x","volume":"585","author":"M. E McCauley","year":"2020","unstructured":"McCauley, M. E. et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature 585, 96\u2013101 (2020).","journal-title":"Nature"},{"key":"7790_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00401-024-02688-z","volume":"147","author":"C Marques","year":"2024","unstructured":"Marques, C. et al. Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol. 147, 56 (2024).","journal-title":"Acta Neuropathol."},{"key":"7790_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.aav9776","volume":"364","author":"S Maniatis","year":"2019","unstructured":"Maniatis, S. et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 364, 89\u201393 (2019).","journal-title":"Science"},{"key":"7790_CR19","doi-asserted-by":"publisher","first-page":"E756","DOI":"10.1073\/pnas.1222361110","volume":"110","author":"H. P Phatnani","year":"2013","unstructured":"Phatnani, H. P. et al. Intricate interplay between astrocytes and motor neurons in ALS. Proc. Natl. Acad. Sci. USA 110, E756\u2013E765 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7790_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581.e9 (2017).","journal-title":"Immunity"},{"key":"7790_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska, A. et al. Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration. Cell 173, 1073\u20131081 (2018).","journal-title":"Cell"},{"key":"7790_CR22","doi-asserted-by":"publisher","first-page":"110158","DOI":"10.1016\/j.celrep.2021.110158","volume":"37","author":"S.-H Lee","year":"2021","unstructured":"Lee, S.-H. et al. TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease. Cell Rep. 37, 110158 (2021).","journal-title":"Cell Rep."},{"key":"7790_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2018.00218","volume":"9","author":"Z Huang","year":"2018","unstructured":"Huang, Z. et al. Circadian rhythm dysfunction accelerates disease progression in a mouse model with amyotrophic lateral sclerosis. Front. Neurol. 9, 218 (2018).","journal-title":"Front. Neurol."},{"key":"7790_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1474-4422(18)30461-7","volume":"18","author":"Y Leng","year":"2019","unstructured":"Leng, Y., Musiek, E. S., Hu, K., Cappuccio, F. P. & Yaffe, K. Association between circadian rhythms and neurodegenerative diseases. Lancet Neurol. 18, 307\u2013318 (2019).","journal-title":"Lancet Neurol."},{"key":"7790_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","volume":"14","author":"P. C Wong","year":"1995","unstructured":"Wong, P. C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105\u20131116 (1995).","journal-title":"Neuron"},{"key":"7790_CR26","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"M. E Gurney","year":"1994","unstructured":"Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772\u20131775 (1994).","journal-title":"Science"},{"key":"7790_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nbd.2017.02.004","volume":"105","author":"K. J De Vos","year":"2017","unstructured":"De Vos, K. J. & Hafezparast, M. Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research? Neurobiol. Dis. 105, 283\u2013299 (2017).","journal-title":"Neurobiol. Dis."},{"key":"7790_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fncel.2014.00117","volume":"8","author":"D Brites","year":"2014","unstructured":"Brites, D. & Vaz, A. R. Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front. Cell Neurosci. 8, 117 (2014).","journal-title":"Front. Cell Neurosci."},{"key":"7790_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97928-7","volume":"11","author":"T Singh","year":"2021","unstructured":"Singh, T. et al. Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated. Sci. Rep. 11, 18916 (2021).","journal-title":"Sci. Rep."},{"key":"7790_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"H. M Lazear","year":"2019","unstructured":"Lazear, H. M., Schoggins, J. W. & Diamond, M. S. Shared and distinct functions of type I and type III interferons. Immunity 50, 907\u2013923 (2019).","journal-title":"Immunity"},{"key":"7790_CR31","doi-asserted-by":"publisher","first-page":"D852","DOI":"10.1093\/nar\/gkn732","volume":"37","author":"S. A Samarajiwa","year":"2009","unstructured":"Samarajiwa, S. A., Forster, S., Auchettl, K. & Hertzog, P. J. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 37, D852\u2013D857 (2009).","journal-title":"Nucleic Acids Res."},{"key":"7790_CR32","doi-asserted-by":"publisher","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","volume":"41","author":"I Rusinova","year":"2013","unstructured":"Rusinova, I. et al. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41, D1040\u2013D1046 (2013).","journal-title":"Nucleic Acids Res."},{"key":"7790_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1073\/pnas.92.3.689","volume":"92","author":"M. E Ripps","year":"1995","unstructured":"Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H. & Gordon, J. W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 92, 689\u2013693 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7790_CR34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13770-023-00536-x","volume":"20","author":"K Chen","year":"2023","unstructured":"Chen, K., Xu, M., Lu, F. & He, Y. Development of Matrix Metalloproteinases-Mediated Extracellular Matrix Remodeling in Regenerative Medicine: A Mini Review. Tissue Eng. Regen. Med. 20, 661\u2013670 (2023).","journal-title":"Tissue Eng. Regen. Med."},{"key":"7790_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1177\/1352458514560925","volume":"21","author":"A Trentini","year":"2015","unstructured":"Trentini, A. et al. TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis. Mult. Scler. 21, 1121\u20131130 (2015).","journal-title":"Mult. Scler."},{"key":"7790_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1191\/1352458505ms1193oa","volume":"11","author":"C Avolio","year":"2005","unstructured":"Avolio, C. et al. Serum MMP-9\/TIMP-1 and MMP-2\/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult. Scler. 11, 441\u2013446 (2005).","journal-title":"Mult. Scler."},{"key":"7790_CR37","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/brain\/124.9.1743","volume":"124","author":"R. L Lindberg","year":"2001","unstructured":"Lindberg, R. L. et al. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124, 1743\u20131753 (2001).","journal-title":"Brain"},{"key":"7790_CR38","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/NEN.0b013e3182294fad","volume":"70","author":"J Skuljec","year":"2011","unstructured":"Skuljec, J. et al. Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter. J. Neuropathol. Exp. Neurol. 70, 758\u2013769 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"7790_CR39","doi-asserted-by":"publisher","first-page":"9553","DOI":"10.3390\/ijms22179553","volume":"22","author":"L. C Fern\u00e1ndez-Beltr\u00e1n","year":"2021","unstructured":"Fern\u00e1ndez-Beltr\u00e1n, L. C. et al. A Transcriptomic Meta-Analysis Shows Lipid Metabolism Dysregulation as an Early Pathological Mechanism in the Spinal Cord of SOD1 Mice. Int. J. Mol. Sci. 22, 9553 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"7790_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-pathol-020117-043952","volume":"14","author":"M. K Crow","year":"2019","unstructured":"Crow, M. K., Olferiev, M. & Kirou, K. A. Type I interferons in autoimmune disease. Annu. Rev. Pathol. 14, 369\u2013393 (2019).","journal-title":"Annu. Rev. Pathol."},{"key":"7790_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","volume":"14","author":"T. L. W Muskardin","year":"2018","unstructured":"Muskardin, T. L. W. & Niewold, T. B. Type I interferon in rheumatic diseases. Nat. Rev. Rheumatol. 14, 214\u2013228 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"7790_CR42","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","volume":"27","author":"A Park","year":"2020","unstructured":"Park, A. & Iwasaki, A. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19. Cell Host Microbe 27, 870\u2013878 (2020).","journal-title":"Cell Host Microbe"},{"key":"7790_CR43","doi-asserted-by":"publisher","first-page":"13500","DOI":"10.1093\/nar\/gku1228","volume":"42","author":"M Pujato","year":"2014","unstructured":"Pujato, M., Kieken, F., Skiles, A. A., Tapinos, N. & Fiser, A. Prediction of DNA binding motifs from 3D models of transcription factors; identifying TLX3 regulated genes. Nucleic Acids Res. 42, 13500\u201313512 (2014).","journal-title":"Nucleic Acids Res."},{"key":"7790_CR44","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00109-009-0520-x","volume":"87","author":"M. R Thompson","year":"2009","unstructured":"Thompson, M. R., Xu, D. & Williams, B. R. G. ATF3 transcription factor and its emerging roles in immunity and cancer. J. Mol. Med. 87, 1053\u20131060 (2009).","journal-title":"J. Mol. Med."},{"key":"7790_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12929-014-0110-2","volume":"22","author":"C.-Y Ko","year":"2015","unstructured":"Ko, C.-Y., Chang, W.-C. & Wang, J.-M. Biological roles of CCAAT\/Enhancer-binding protein delta during inflammation. J. Biomed. Sci. 22, 6 (2015).","journal-title":"J. Biomed. Sci."},{"key":"7790_CR46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ymthe.2019.02.018","volume":"27","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice. Mol. Ther. 27, 999\u20131016 (2019).","journal-title":"Mol. Ther."},{"key":"7790_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s42003-022-03128-y","volume":"5","author":"M MacLean","year":"2022","unstructured":"MacLean, M., L\u00f3pez-D\u00edez, R., Vasquez, C., Gugger, P. F. & Schmidt, A. M. Neuronal-glial communication perturbations in murine SOD1G93A spinal cord. Commun. Biol. 5, 177 (2022).","journal-title":"Commun. Biol."},{"key":"7790_CR48","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"7790_CR49","first-page":"101128","volume":"28","author":"K Kurowarabe","year":"2021","unstructured":"Kurowarabe, K., Endo, M., Kobayashi, D. & Hayasaka, H. CXCL12-stimulated lymphocytes produce secondary stimulants that affect the surrounding cell chemotaxis. Biochem. Biophys. Rep. 28, 101128 (2021).","journal-title":"Biochem. Biophys. Rep."},{"key":"7790_CR50","doi-asserted-by":"publisher","first-page":"D8","DOI":"10.1093\/nar\/gks1189","volume":"41","author":"NCBI Resource Coordinators","year":"2013","unstructured":"NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 41, D8\u2013D20 (2013).","journal-title":"Nucleic Acids Res."},{"key":"7790_CR51","doi-asserted-by":"publisher","first-page":"767221","DOI":"10.3389\/fcell.2021.767221","volume":"9","author":"E Pangou","year":"2021","unstructured":"Pangou, E. & Sumara, I. The multifaceted regulation of mitochondrial dynamics during mitosis. Front. Cell Dev. Biol. 9, 767221 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"7790_CR52","doi-asserted-by":"publisher","first-page":"jcs259387","DOI":"10.1242\/jcs.259387","volume":"135","author":"C Mayya","year":"2022","unstructured":"Mayya, C. et al. The roles of dynein and myosin VI motor proteins in endocytosis. J. Cell Sci. 135, jcs259387 (2022).","journal-title":"J. Cell Sci."},{"key":"7790_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-981-13-3065-0_2","volume":"1112","author":"D Dwivedi","year":"2018","unstructured":"Dwivedi, D. & Sharma, M. Multiple roles, multiple adaptors: dynein during cell cycle. Adv. Exp. Med. Biol. 1112, 13\u201330 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"7790_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00412-014-0468-7","volume":"123","author":"J. A Raaijmakers","year":"2014","unstructured":"Raaijmakers, J. A. & Medema, R. H. Function and regulation of dynein in mitotic chromosome segregation. Chromosoma 123, 407\u2013422 (2014).","journal-title":"Chromosoma"},{"key":"7790_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01283-z","volume":"8","author":"G. E Tyzack","year":"2017","unstructured":"Tyzack, G. E. et al. A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nat. Commun. 8, 1164 (2017).","journal-title":"Nat. Commun."},{"key":"7790_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ebiom.2019.11.026","volume":"50","author":"A Birger","year":"2019","unstructured":"Birger, A. et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine 50, 274\u2013289 (2019).","journal-title":"EBioMedicine"},{"key":"7790_CR57","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.celrep.2017.05.024","volume":"19","author":"C. E Hall","year":"2017","unstructured":"Hall, C. E. et al. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS. Cell Rep. 19, 1739\u20131749 (2017).","journal-title":"Cell Rep."},{"key":"7790_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-022-00591-3","volume":"18","author":"K Stoklund Dittlau","year":"2023","unstructured":"Stoklund Dittlau, K. et al. FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms. Mol. Neurodegener. 18, 5 (2023).","journal-title":"Mol. Neurodegener."},{"key":"7790_CR59","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1093\/nar\/gkab115","volume":"49","author":"O. J Ziff","year":"2021","unstructured":"Ziff, O. J. et al. Reactive astrocytes in ALS display diminished intron retention. Nucleic Acids Res. 49, 3168\u20133184 (2021).","journal-title":"Nucleic Acids Res."},{"key":"7790_CR60","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1073\/pnas.1114981109","volume":"109","author":"S.-Y Liu","year":"2012","unstructured":"Liu, S.-Y., Sanchez, D. J., Aliyari, R., Lu, S. & Cheng, G. Systematic identification of type I and type II interferon-induced antiviral factors. Proc. Natl. Acad. Sci. USA 109, 4239\u20134244 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7790_CR61","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786\u2013791 (2013).","journal-title":"Science"},{"key":"7790_CR62","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/jnnp-2013-307135","volume":"85","author":"A Eisen","year":"2014","unstructured":"Eisen, A., Kiernan, M., Mitsumoto, H. & Swash, M. Amyotrophic lateral sclerosis: a long preclinical period? J. Neurol. Neurosurg. Psychiatry 85, 1232\u20131238 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"7790_CR63","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.4049\/jimmunol.1202222","volume":"191","author":"V Peperzak","year":"2013","unstructured":"Peperzak, V. et al. CD8+ T cells produce the chemokine CXCL10 in response to CD27\/CD70 costimulation to promote generation of the CD8+ effector T cell pool. J. Immunol. 191, 3025\u20133036 (2013).","journal-title":"J. Immunol."},{"key":"7790_CR64","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3389\/fimmu.2020.00976","volume":"11","author":"N Karin","year":"2020","unstructured":"Karin, N. CXCR3 ligands in cancer and autoimmunity, chemoattraction of effector T cells, and beyond. Front. Immunol. 11, 976 (2020).","journal-title":"Front. Immunol."},{"key":"7790_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","volume":"50","author":"J. I Engelhardt","year":"1993","unstructured":"Engelhardt, J. I., Tajti, J. & Appel, S. H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 50, 30\u201336 (1993).","journal-title":"Arch. Neurol."},{"key":"7790_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-76","volume":"7","author":"M Fiala","year":"2010","unstructured":"Fiala, M. et al. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J. Neuroinflam.7, 76 (2010).","journal-title":"J. Neuroinflam."},{"key":"7790_CR67","first-page":"691","volume":"140","author":"T Kawamata","year":"1992","unstructured":"Kawamata, T., Akiyama, H., Yamada, T. & McGeer, P. L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140, 691\u2013707 (1992).","journal-title":"Am. J. Pathol."},{"key":"7790_CR68","doi-asserted-by":"publisher","first-page":"17913","DOI":"10.1073\/pnas.0804610105","volume":"105","author":"I. M Chiu","year":"2008","unstructured":"Chiu, I. M. et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. USA 105, 17913\u201317918 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7790_CR69","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0807419105","volume":"105","author":"D. R Beers","year":"2008","unstructured":"Beers, D. R., Henkel, J. S., Zhao, W., Wang, J. & Appel, S. H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl. Acad. Sci. USA 105, 15558\u201315563 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7790_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1440-1789.2007.00873.x","volume":"28","author":"K Okamoto","year":"2008","unstructured":"Okamoto, K., Mizuno, Y. & Fujita, Y. Bunina bodies in amyotrophic lateral sclerosis. Neuropathology 28, 109\u2013115 (2008).","journal-title":"Neuropathology"},{"key":"7790_CR71","first-page":"355","volume":"36","author":"R. J Fallis","year":"1982","unstructured":"Fallis, R. J. & Weiner, L. P. Further studies in search of a virus in amyotrophic lateral sclerosis. Adv. Neurol. 36, 355\u2013361 (1982).","journal-title":"Adv. Neurol."},{"key":"7790_CR72","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(88)92129-0","volume":"1","author":"C. N Martyn","year":"1988","unstructured":"Martyn, C. N., Barker, D. J. & Osmond, C. Motoneuron disease and past poliomyelitis in England and Wales. Lancet 1, 1319\u20131322 (1988).","journal-title":"Lancet"},{"key":"7790_CR73","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/00001756-199306000-00056","volume":"4","author":"M. E Westarp","year":"1993","unstructured":"Westarp, M. E. et al. Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. Neuroreport 4, 819\u2013822 (1993).","journal-title":"Neuroreport"},{"key":"7790_CR74","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000150094","volume":"30","author":"H Bartfeld","year":"1989","unstructured":"Bartfeld, H. et al. Enteroviral-related antigen in circulating immune complexes of amyotrophic lateral sclerosis patients. Intervirology 30, 202\u2013212 (1989).","journal-title":"Intervirology"},{"key":"7790_CR75","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ana.410070427","volume":"7","author":"A Rissanen","year":"1980","unstructured":"Rissanen, A., Palo, J., Myllyl\u00e4, G. & Cantell, K. Interferon therapy for ALS. Ann. Neurol. 7, 392 (1980).","journal-title":"Ann. Neurol."},{"key":"7790_CR76","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1212\/WNL.54.2.469","volume":"54","author":"E Beghi","year":"2000","unstructured":"Beghi, E. et al. A randomized controlled trial of recombinant interferon beta-1a in ALS. Italian Amyotrophic Lateral Sclerosis Study Group. Neurology 54, 469\u2013474 (2000).","journal-title":"Neurology"},{"key":"7790_CR77","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1212\/WNL.36.8.1137","volume":"36","author":"J. S Mora","year":"1986","unstructured":"Mora, J. S. et al. Intrathecal administration of natural human interferon alpha in amyotrophic lateral sclerosis. Neurology 36, 1137\u20131140 (1986).","journal-title":"Neurology"},{"key":"7790_CR78","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1001\/archneur.1986.00520090061018","volume":"43","author":"M. C Dalakas","year":"1986","unstructured":"Dalakas, M. C., Aksamit, A. J., Madden, D. L. & Sever, J. L. Administration of recombinant human leukocyte alpha 2-interferon in patients with amyotrophic lateral sclerosis. Arch. Neurol. 43, 933\u2013935 (1986).","journal-title":"Arch. Neurol."},{"key":"7790_CR79","first-page":"81","volume":"30","author":"M. E Westarp","year":"1992","unstructured":"Westarp, M. E. et al. Dermal, serological and CSF changes in amyotrophic lateral sclerosis with and without intrathecal interferon beta treatment. Int J. Clin. Pharm. Ther. Toxicol. 30, 81\u201393 (1992).","journal-title":"Int J. Clin. Pharm. Ther. Toxicol."},{"key":"7790_CR80","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","volume":"125","author":"E. A Winkler","year":"2013","unstructured":"Winkler, E. A. et al. Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol. 125, 111\u2013120 (2013).","journal-title":"Acta Neuropathol."},{"key":"7790_CR81","doi-asserted-by":"publisher","first-page":"e1205","DOI":"10.1371\/journal.pone.0001205","volume":"2","author":"S Garbuzova-Davis","year":"2007","unstructured":"Garbuzova-Davis, S. et al. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2, e1205 (2007).","journal-title":"PLoS One"},{"key":"7790_CR82","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/archneur.1990.00530110068019","volume":"47","author":"J. I Engelhardt","year":"1990","unstructured":"Engelhardt, J. I. & Appel, S. H. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch. Neurol. 47, 1210\u20131216 (1990).","journal-title":"Arch. Neurol."},{"key":"7790_CR83","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0165-5728(84)90042-0","volume":"6","author":"H Donnenfeld","year":"1984","unstructured":"Donnenfeld, H., Kascsak, R. J. & Bartfeld, H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J. Neuroimmunol. 6, 51\u201357 (1984).","journal-title":"J. Neuroimmunol."},{"key":"7790_CR84","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00313720","volume":"231","author":"A Leonardi","year":"1984","unstructured":"Leonardi, A., Abbruzzese, G., Arata, L., Cocito, L. & Vische, M. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis. J. Neurol. 231, 75\u201378 (1984).","journal-title":"J. Neurol."},{"key":"7790_CR85","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/glia.23028","volume":"64","author":"B. S Main","year":"2016","unstructured":"Main, B. S. et al. Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson\u2019s disease. Glia 64, 1590\u20131604 (2016).","journal-title":"Glia"},{"key":"7790_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01590-1","volume":"22","author":"P Quan","year":"2024","unstructured":"Quan, P. et al. Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson\u2019s disease. Cell Commun. Signal. 22, 212 (2024).","journal-title":"Cell Commun. Signal."},{"key":"7790_CR87","doi-asserted-by":"crossref","unstructured":"Roy, E. R. et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J. Clin. Invest. 130, 1912\u20131930 (2020).","DOI":"10.1172\/JCI133737"},{"key":"7790_CR88","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","volume":"46","author":"E Afgan","year":"2018","unstructured":"Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537\u2013W544 (2018).","journal-title":"Nucleic Acids Res."},{"key":"7790_CR89","doi-asserted-by":"publisher","first-page":"W345","DOI":"10.1093\/nar\/gkac247","volume":"50","author":"Galaxy Community","year":"2022","unstructured":"Galaxy Community. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res. 50, W345\u2013W351 (2022).","journal-title":"Nucleic Acids Res."},{"key":"7790_CR90","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1093\/bioinformatics\/bts611","volume":"28","author":"E Kopylova","year":"2012","unstructured":"Kopylova, E., No\u00e9, L. & Touzet, H. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics 28, 3211\u20133217 (2012).","journal-title":"Bioinformatics"},{"key":"7790_CR91","doi-asserted-by":"publisher","first-page":"D1115","DOI":"10.1093\/nar\/gkab959","volume":"50","author":"B. T Lee","year":"2022","unstructured":"Lee, B. T. et al. The UCSC Genome Browser database: 2022 update. Nucleic Acids Res 50, D1115\u2013D1122 (2022).","journal-title":"Nucleic Acids Res"},{"key":"7790_CR92","doi-asserted-by":"publisher","first-page":"D1188","DOI":"10.1093\/nar\/gkac1072","volume":"51","author":"L. R Nassar","year":"2023","unstructured":"Nassar, L. R. et al. The UCSC Genome Browser database: 2023 update. Nucleic Acids Res. 51, D1188\u2013D1195 (2023).","journal-title":"Nucleic Acids Res."},{"key":"7790_CR93","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"M. D Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"7790_CR94","first-page":"1438","volume":"5","author":"Y Chen","year":"2016","unstructured":"Chen, Y., Lun, A. T. L. & Smyth, G. K. From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. [version 2; peer review: 5 approved]. F1000Res 5, 1438 (2016).","journal-title":"F1000Res"},{"key":"7790_CR95","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc.: Ser. B (Methodol.) 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc.: Ser. B (Methodol.)"},{"key":"7790_CR96","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"7790_CR97","doi-asserted-by":"crossref","unstructured":"Lund, S. P., Nettleton, D., McCarthy, D. J. & Smyth, G. K. Detecting differential expression in RNA-sequence data using quasi-likelihood with shrunken dispersion estimates. Stat. Appl. Genet. Mol. Biol. 11, 1\u201342 (2012).","DOI":"10.1515\/1544-6115.1826"},{"key":"7790_CR98","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570, 332\u2013337 (2019).","journal-title":"Nature"},{"key":"7790_CR99","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41418-020-0509-0","volume":"27","author":"C. S Ng","year":"2020","unstructured":"Ng, C. S., Kasumba, D. M., Fujita, T. & Luo, H. Spatio-temporal characterization of the antiviral activity of the XRN1-DCP1\/2 aggregation against cytoplasmic RNA viruses to prevent cell death. Cell Death Differ. 27, 2363\u20132382 (2020).","journal-title":"Cell Death Differ."},{"key":"7790_CR100","doi-asserted-by":"crossref","unstructured":"Herskovits, A. Z. et al. SIRT1 deacetylase in aging-induced neuromuscular degeneration and amyotrophic lateral sclerosis. Aging Cell 17, e12839 (2018).","DOI":"10.1111\/acel.12839"},{"key":"7790_CR101","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Beltr\u00e1n, L. C. et al. Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1G93A mice by reducing inflammatory pathways in the adipose tissue. Sci. Rep. 14, 2671 (2024).","DOI":"10.1038\/s41598-024-52439-z"},{"key":"7790_CR102","doi-asserted-by":"crossref","unstructured":"Luisier, R. et al. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat. Commun. 9, 2010 (2018).","DOI":"10.1038\/s41467-018-04373-8"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07790-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T01:45:48Z","timestamp":1740966348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07790-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,2]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7790"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-07790-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,2]]},"assertion":[{"value":"21 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}